Sticker Shock

It may be an old drug, but its new use fetches a new -- and much higher -- price. Previously a treatment for cancer, Depo-Provera was approved in the U.S. in October as a contraceptive. But its maker, Upjohn, is now charging doctors and clinics around $30 for a three-month shot -- more than double its earlier price -- which means women will pay about $50. Upjohn maintains it is recouping drug-development costs, but doctors argue that research ended long ago and that many countries have used Depo-Provera as a birth-control agent for years.


Want the full story?

Subscribe Now


Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!